Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 4302 | 43.075 |
09:34 ET | 200 | 43.005 |
09:36 ET | 100 | 42.99 |
09:38 ET | 304 | 42.805 |
09:39 ET | 1452 | 42.87 |
09:41 ET | 100 | 42.9575 |
09:43 ET | 300 | 42.95 |
09:45 ET | 1300 | 42.86 |
09:48 ET | 500 | 43.03 |
09:50 ET | 500 | 43.185 |
09:52 ET | 100 | 43.11 |
09:54 ET | 200 | 42.98 |
09:56 ET | 4798 | 42.96 |
09:57 ET | 4430 | 43.115 |
09:59 ET | 900 | 43 |
10:03 ET | 600 | 42.66 |
10:06 ET | 1500 | 42.673 |
10:08 ET | 300 | 42.72 |
10:10 ET | 200 | 42.695 |
10:12 ET | 200 | 42.52 |
10:14 ET | 1266 | 42.31 |
10:15 ET | 100 | 42.38 |
10:17 ET | 100 | 42.28 |
10:19 ET | 300 | 42.22 |
10:21 ET | 3470 | 42.7 |
10:24 ET | 3574 | 42.96 |
10:26 ET | 800 | 42.99 |
10:28 ET | 703 | 42.945 |
10:30 ET | 1300 | 42.98 |
10:32 ET | 331 | 42.9668 |
10:33 ET | 200 | 42.925 |
10:35 ET | 300 | 43.05 |
10:37 ET | 352 | 43.14 |
10:39 ET | 594 | 43.115 |
10:42 ET | 100 | 43.18 |
10:44 ET | 100 | 43.16 |
10:46 ET | 1100 | 42.87 |
10:48 ET | 200 | 43.05 |
10:50 ET | 300 | 43 |
10:51 ET | 322 | 42.99 |
10:53 ET | 799 | 42.915 |
10:55 ET | 1400 | 43.04 |
10:57 ET | 200 | 42.95 |
11:00 ET | 300 | 43.055 |
11:04 ET | 400 | 43.09 |
11:06 ET | 800 | 42.91 |
11:08 ET | 600 | 42.84 |
11:09 ET | 200 | 42.82 |
11:11 ET | 700 | 42.815 |
11:13 ET | 700 | 42.735 |
11:15 ET | 200 | 42.695 |
11:18 ET | 1200 | 42.82 |
11:20 ET | 100 | 42.815 |
11:22 ET | 400 | 42.815 |
11:24 ET | 500 | 42.815 |
11:26 ET | 1400 | 42.86 |
11:27 ET | 1600 | 42.855 |
11:29 ET | 100 | 42.85 |
11:31 ET | 2200 | 42.955 |
11:33 ET | 100 | 42.955 |
11:36 ET | 1200 | 42.855 |
11:38 ET | 2029 | 42.8775 |
11:40 ET | 100 | 42.875 |
11:42 ET | 1503 | 42.766 |
11:44 ET | 500 | 42.76 |
11:45 ET | 300 | 42.755 |
11:47 ET | 800 | 42.71 |
11:49 ET | 400 | 42.75 |
11:51 ET | 300 | 42.545 |
11:54 ET | 100 | 42.55 |
11:56 ET | 500 | 42.525 |
11:58 ET | 600 | 42.58 |
12:00 ET | 773 | 42.57 |
12:02 ET | 400 | 42.49 |
12:03 ET | 100 | 42.44 |
12:05 ET | 1204 | 42.45 |
12:07 ET | 200 | 42.44 |
12:09 ET | 1007 | 42.515 |
12:12 ET | 1100 | 42.57 |
12:14 ET | 700 | 42.5 |
12:16 ET | 400 | 42.36 |
12:18 ET | 100 | 42.35 |
12:21 ET | 600 | 42.35 |
12:23 ET | 1600 | 42.34 |
12:25 ET | 200 | 42.44 |
12:30 ET | 4186 | 42.23 |
12:32 ET | 700 | 42.21 |
12:34 ET | 617 | 42.08 |
12:36 ET | 528 | 42.09 |
12:38 ET | 3391 | 42.13 |
12:39 ET | 200 | 42.09 |
12:41 ET | 716 | 42.1157 |
12:43 ET | 800 | 42.01 |
12:45 ET | 400 | 41.99 |
12:48 ET | 400 | 41.91 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.5B | -6.6x | --- |
Celldex Therapeutics Inc | 2.6B | -13.3x | --- |
IDEAYA Biosciences Inc | 2.7B | -17.1x | --- |
Geron Corp | 2.6B | -12.0x | --- |
Intellia Therapeutics Inc | 2.2B | -4.1x | --- |
Structure Therapeutics Inc | 2.3B | -16.4x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -6.6x |
Price/Sales (TTM) | 83.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.